ClinicalTrials.gg
Sign In

Pelvic Neoplasms clinical trials

The registry lists 82 studies for Pelvic Neoplasms across more than 10 countries. 28 are recruiting or about to start. 45 of them are mainly about Pelvic Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Pelvic Neoplasms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
35
Recruiting
23
Status unknown
9
Not yet recruiting
5
Active, not recruiting
5
Terminated
4

Phase

Phase 1
8
Phase 3
6
Phase 2
5
Early Phase 1
2

Where

United States
28
France
8
China
7
United Kingdom
6
Italy
4
Canada
3

Who runs them

Varian, a Siemens Healthineers Company (4) · M.D. Anderson Cancer Center (3) · Assiut University (3) · Washington University School of Medicine (3) · Eli Lilly and Company (2) · Mayo Clinic (2) · IRCCS Azienda Ospedaliero-Universitaria di Bologna (2) · Institut du Cancer de Montpellier - Val d'Aurelle (2)

What is being tested here

Drugs under test in Pelvic Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Pafolacianine111
Iohexol002
Sunitinib001
Lidocaine001
Ketamine001
Dexmedetomidine001
Vorinostat001
FS 069001
Gemcitabine011
Talaporfin001

Coming up

2phase 3 studies under way
9studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 9, phase 3 first

Who these studies take

Of the 23 Pelvic Neoplasms studies recruiting now, 16 (70%) set no upper age limit and 3 (13%) stop at 75 or younger. 5 (22%) take children under 18. 5 (22%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 23
AgeWomenMen
105 (22%)5 (22%)
1821 (91%)16 (70%)
3020 (87%)15 (65%)
4020 (87%)15 (65%)
5020 (87%)15 (65%)
6520 (87%)15 (65%)
7520 (87%)15 (65%)
8517 (74%)12 (52%)

Across all 82 studies, recruiting or not: 15% stop at 75 or younger and 9% at 65; 15% take children; 16% are for women only and 0% for men only; 7% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Pelvic Neoplasms studies take

Of 23 interventional studies with no phase under Pelvic Neoplasms, half reached primary completion within 21 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase21 mo18–30 · 23 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting1

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 82. Browse all 82 → or search them.